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2Synthetic drugs constitute one of the most significant 
drug problems worldwide. After cannabis, amphet-
amine-type stimulants (ATS) are the second most 
widely used drugs across the globe, with use levels 
often exceeding those of heroin and/or cocaine. Along 
with ATS, the continued growth of the new psychoactive 
substances (NPS) market over the last years has become 
a policy challenge and a major international concern. 
A growing interplay between these new drugs and tra-
ditional illicit drug markets is being observed. By July 
2016, the emergence of NPS had been reported from 
102 countries and territories. Trends on the synthetic 
drug market evolve quickly each year. 
The UNODC Global Synthetics Monitoring: Analyses, 
Reporting and Trends (SMART) Programme enhances 
the capacity of Member States in priority regions to 
generate, manage, analyse, report and use synthetic 
drug information to design effective policy and pro-
gramme interventions. Launched in September 2008, 
the Global SMART Programme provides capacity building 
to laboratory personnel, law enforcement and research 
officers in the Pacific, East and South-East Asia, South 
Asia, the Near and Middle East, Africa and Latin America; 
and regularly reviews the global amphetamine-type 
stimulants and new psychoactive substances situation. 
Its main products include online drug data collection, 
situation reports, regional assessments and the UNODC 
Early Warning Advisory (EWA) on new psychoactive 
substances. The EWA is a webportal that offers regu-
lar updates on new psychoactive substances, including 
trend data on emergence and persistence, chemical 
data, supporting documentation on laboratory analysis 
and national legislative responses (available at: www.
unodc.org/NPS).
The Global SMART Update (GSU) series is published 
twice a year in English, Spanish and Russian and provides 
information on emerging patterns and trends of the 
global synthetic drug situation in a concise format. Each 
issue of the Global SMART Update contains a special 
segment and short segments on the topic of interest.* 
Electronic copies of the Global SMART Updates and 
other publications are available at: www.unodc.org/
unodc/en/scientists/publications-smart.html. Past issues 
have covered topics such as UNGASS 2016 recommenda-
tions, injecting use of synthetic drugs, legal responses to 
NPS, key facts about synthetic cannabinoids and regional 
patterns of methamphetamine manufacture.
About the SMART Update Content
SPECIAL SEGMENT 3
SHORT SEGMENTS 8
BEIJING, China – September 2015 8
BEIJING, China – May 2015 8
TOKYO, Japan – August 2016 8
HELSINKI, Finland – June 2015 8
STOCKHOLM, Sweden – August 2016 9
TALLINN, Estonia – July 2016 9
VIENNA, Austria – May 2016 9
VIENNA, Austria – November 2016 9
GENEVA, Switzerland – November 2016 10
BRUSSELS, Belgium – 2015 10
DUBLIN, Ireland – 2016 10
SÃO PAULO, Brazil – September 2016 10
OTTAWA, Canada – September 2016 11
LOS ANGELES, California – March 2016 11
BRITISH COLUMBIA, Canada – June 2016 11
WASHINGTON D.C., United States – 2016 11
* The information and data contained within this report are from official Government reports, press releases, scientific journals or incidents confirmed by 
UNODC Field Offices. An asterisk (*) indicates that information is preliminary as it stems from ‘open sources’ where UNODC is waiting for official confir-
mation. This report has not been formally edited. The contents of this publication do not necessarily reflect the views or policies of UNODC or contributory 
organizations and neither do they imply any endorsement. Suggested citation: UNODC, Global SMART Update Volume 17, March 2017.
GLOBAL 
SMART 
UPDATE
3Introduction
Recent years have seen a sharp rise 
in opioid-related overdose deaths 
mainly in North America, and to a 
certain extent, in Europe. While the 
challenge posed by these fatalities 
is complex, more evidence is emerg-
ing about the role fentanyl and its 
analogues play in the current crisis. 
Fentanyl itself is a powerful opioid 
analgesic, with an established place 
in medicine. Yet, there has always 
been concern about its potential for 
abuse and dependence, and it was 
therefore placed under international 
control as far back as 1964. In the 
1970s and 1980s, products con-
taining fentanyl and its analogues 
appeared on the illicit drug market, 
and became notorious for accidental 
overdoses.1 The problem seems to 
have resurfaced and the clandes-
tine manufacturing of fentanyl has 
risen to unprecedented levels. The 
required materials and equipment 
for manufacture are readily available 
online, at low cost. This situation is 
aggravated by the rapid emergence 
of novel non-fentanyl analogues 
which have not been approved for 
medical use.
North America is particularly affected 
by an opioid overdose crisis. While 
originally, the sharp rise in over-
doses was attributed to heroin, the 
current crisis is mainly attributed to 
clandestinely manufactured fentanyl 
1 Henderson GL. Fentanyl-related deaths: 
demographics, circumstances, and toxicology 
of 112 cases. Journal of Forensic Science. 
1991 Mar 1;36(2):422-33.
and fentanyl analogues. Evidence on 
fatalities associated with emerging 
fentanyl analogues is accumulating, 
also, in other regions of the world. 
The pills and powders containing 
such substances sold on the illicit 
market pose a threat to public health 
because of the variable quantity and 
potency of the active components, 
which in extreme cases, such as with 
carfentanil, may be 10,000 times 
more potent than morphine. Such 
products can prove particularly dan-
gerous when sold as street heroin, 
together with heroin or as counter-
feit prescription drugs, without the 
user’s knowledge.
This publication aims to inform 
about the growing complexity of the 
opioid market, in particular the fen-
tanyl group, international controls, 
evolving patterns of use and associ-
ated risks, global developments in 
manufacture and trafficking of fen-
tanyl analogues and their precursors.
Good medicines,  
bad drugs?
Fentanyl belongs to a class of potent 
opioid analgesics, the 4-anilidopi-
peridines. These synthetic opioids 
have a high affinity for the µ-opioid 
receptor, which presents both bene-
fits and drawbacks. On the one hand, 
strong µ-opioid receptor agonists 
from the fentanyl family have excel-
lent pain-relieving properties. On the 
other hand, such drugs are liable to 
abuse and have high dependence-
producing properties.
Fentanyl is the strongest opioid 
available for medical use in humans, 
with about 100 times the potency of 
morphine2. It is highly valued for its 
analgesic and sedative effects and 
widely used in the management of 
severe pain and in anaesthesia. The 
three fentanyl analogues approved 
for pharmaceutical use, sufentanil, 
alfentanil and remifentanil, have 
very short onset and duration of 
action, and their medical use is lim-
ited to intravenous anaesthesia3. 
Carfentanil, estimated to be about 
10,000 times more potent than 
morphine4, is intended only for vet-
erinary use on large animals, and not 
approved for medical use in humans.
The liability of fentanyl and its 
analogues to abuse and the depen-
dence-potential are reflected in the 
international legislative responses. 
Fentanyl was first synthesized in 
1959, and was placed under inter-
national control as a Schedule 1 
substance in 1964 under the Single 
Convention on Narcotic Drugs of 
1961. During the ensuing decades, 
the list of scheduled substances 
has grown to include all fentanyl 
analogues approved for human 
medical use (sufentanil in 1980, 
alfentanil in 1984, and remifentanil 
in 1999), and several analogues 
which have not been developed 
into pharmaceutical products 
(acetyl-alpha- methylfentanyl, alpha-
methylfentanyl and 3-methylfentanyl 
were placed under international 
control in 1988, and alpha-methyl-
thiofentanyl, beta-hydroxyfentanyl, 
beta-hydroxy-3-methylfentanyl, 
3-methylthiofentanyl, para-fluoro-
fentanyl and thiofentanyl in 1990). 
2 Chodoff P, Domino EF. Comparative phar-
macology of drugs used in neuroleptanalge-
sia. Anesthesia and Analgesia, 44 (5) (1965), 
pp. 558–563
3 Lemmens H. Pharmacokinetic-pharmaco-
dynamic relationships for opioids in bal-
anced anaesthesia. Clin Pharmacokinet. 
1995;29:231–242.
4 Janssen PA. Potent, new analgesics, tailor-
made for different purposes. Acta Anaesthe-
siol Scand. 1982 Jun;26(3):262-8.
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ABSTRACT
Fentanyl and its analogues are potent synthetic opioids, which are 
liable to abuse. They are often sold under the guise of heroin or 
prescription medicines, such as oxycodone, and this exacerbates 
the risk of overdose and associated fatalities. An increasing num-
ber of deaths have been associated with the use of fentanyl and 
its analogues, particularly in North America. The facile synthesis of 
a number of these substances, coupled with the ease in obtaining 
the required precursor chemicals and equipment, has led to an 
increase in clandestine manufacture.
Volume 17
SP
EC
IA
L S
EG
M
EN
T
4Nonmedical use of fentanyl and its 
analogues can have severe health 
consequences. Tolerance and depen-
dence develop very fast, and may 
reach extreme levels. Above all, each 
episode of nonmedical use carries a 
high risk of overdose and death as 
a result of respiratory depression 
– a common side-effect of opioids. 
A report from a drug consumption 
room in Sydney found that under 
medical surveillance, the risk of 
overdose upon injecting fentanyl 
was two times higher than upon 
injecting heroin, and eight times 
higher than upon injecting other 
prescription opioids6.
Overdoses can be effectively 
reversed by naloxone, a µ-opioid 
6 Latimer J, Ling S, Flaherty I, Jauncey M, 
Salmon AM. Risk of fentanyl overdose 
among clients of the Sydney Medically 
Supervised Injecting Centre. Int J Drug 
Policy. 2016 Oct 14;37:111-114
These substances were described in 
scientific literature but never devel-
oped into pharmaceutical products. 
Examples include acetylfentanyl, 
butyrfentanyl, furanylfentanyl, 
and ocfentanil. Other substances 
currently present in the illicit opioid 
market are newly designed fentanyl 
analogues, such as acrylfentanyl 
and para-fluoroisobutyrfentanyl. 
The countless possibilities to create 
new compounds by small changes in 
chemical structures pose a growing 
challenge to international control of 
the opioid trade. Between 2012 and 
2016, seventeen fentanyl analogues 
were reported to the UNODC EWA 
from countries in East Asia, Europe 
and North America (see Table 1). So 
far, only one of them, acetylfentanyl, 
has been placed under international 
control. 
Acetylfentanyl was placed under 
international control in 2016, while 
butyrfentanyl has been recom-
mended for control by the WHO5. 
Carfentanil, which was first synthe-
sized in 1974 and remains the most 
potent commercially available opioid 
in the world, is not under interna-
tional control.
Within the last five years, more than 
a dozen additional fentanyl ana-
logues have entered the illicit opioid 
market. Some of these analogues 
have been re-discovered by traffick-
ers from research work carried out 
between the 1960s and 1990s. 
5 Commission on Narcotic Drugs, Recon-
vened fifty-ninth session. Extract from the 
Report of the 38th Expert Committee on 
Drug Dependence, convened from 14 to 
18 November 2016, at WHO headquarters 
in Geneva. 30 November 2016. https://
www.unodc.org/documents/commissions/
CND/CND_Sessions/CND_59Reconvened/
ECN72016_CRP13_V1610192.pdf
1964
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1984
1988
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1999
2013
2015
2016
remifentanil
alfentanil
sufentanil
fentanyl
acetyl-alpha-methylfentanyl, alpha-methylfentanyl, 
3-methylfentanyl
alpha-methyl-thiofentanyl, beta-hydroxyfentanyl, 
beta-hydroxy-3-methylfentanyl, 3-methylthiofentanyl, 
para-ﬂuorofentanyl, thiofentanyl
acrylfentanyl, para-ﬂuoroisobutyrfentanyl
butyrfentanyl, furanylfentanyl
acetylfentanyl, ocfentanil
acetylfentanyl
Fentanyl and analogues controlled under the
1961 Single Convention on Narcotic Drugs
Fentanyl analogues reported to 
the UNODC Early Warning Advisory 
Figure 1: International control of fentanyl and its analogues, 1964-2016
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5Use of illicitly manufactured fen-
tanyl and its analogues amplifies 
the hazards because such products 
lack quality control, are typically not 
portioned in precise doses, and can 
be deadly in minuscule amounts due 
to the extreme potencies. Attempts 
to prepare a single dose by weigh-
ing without precision equipment are 
highly risky. Another approach is to 
bring a larger amount of the drug 
into solution, which is then appor-
tioned into single doses; however, 
errors in calculations can be lethal. 
Users experimenting with new fen-
tanyl analogues, whose potency is 
not well-defined, increase the odds 
of making a fatal mistake.
Clarke I, and Campbell, M. Illicit Fentanyl 
use in Rural Australia – An Exploratory 
Study. 2015 J Alcohol Drug Depend 3:196.
setting, the recreational use of prod-
ucts containing fentanyl may easily 
prove fatal with increase in the 
administered dose, or a change in 
the route of administration (e.g. 
extracting the drug from a trans-
dermal patch into liquid to prepare 
an injection or nasal spray, inhal-
ing volatilized fentanyl, or placing a 
transdermal patch on oral mucous 
membranes). A study conducted in 
rural Australia concluded that users 
typically did not revert to less potent 
opioids after becoming dependent 
on fentanyl, practiced unsafe prepa-
ration and administration methods, 
and their risk of overdose was 
exacerbated by misinformation cir-
culating amongst peers8.
8 Allan J, Herridge N, Griffiths P, Fisher A, 
receptor antagonist medication. 
Importantly, reversing overdoses 
of fentanyl or its analogues often 
requires very high doses of naloxone. 
In response to the growing need for 
overdose treatment, some countries 
have introduced or expanded nalox-
one distribution programs. Canada 
authorised sale of naloxone with-
out prescription, including the nasal 
spray version, in 20167.
Risky practices
Although fentanyl is safe under 
clinical supervision, e.g. in a hospital 
7 Health Canada. Notice - Availability of 
Naloxone Hydrochloride Nasal Spray 
(NARCAN®) in Canada. July 6, 2016. 
(http://www.hc-sc.gc.ca/dhp-mps/prodp-
harma/activit/announce-annonce/notice-avis-
nasal-eng.php)
Figure 2: Development of new fentanyl analogues by small changes in chemical structures.  
(A) fentanyl, (B) acetylfentanyl, (C) butyrfentanyl
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Table 1: NPS fentanyl analogues reported to the UNODC EWA, 2012-2016
COMMON NAME REPORTED IN
3-fluorofentanyl Europe
4-fluorobutyrfentanyl Europe
4-methoxybutyrfentanyl Europe
acetylfentanyl Asia, Europe, North America
acrylfentanyl Asia, Europe
beta-hydroxy-thiofentanyl North America
butyrfentanyl Asia, Europe, North America
despropionylfentanyl Latin America, North America
despropionyl-2-fluorofentanyl Europe
furanylfentanyl Asia, Europe, North America
isobutyrfentanyl Africa, Europe
(iso)butyr-F-fentanyl N-benzyl analogue Europe
methoxyacetylfentanyl Europe
ocfentanil Europe
para-fluoroisobutyrfentanyl North America
tetrahydrofuranylfentanyl Europe
valerylfentanyl Asia, Europe, North America
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6trend in deaths resulting from use 
of diverted pharmaceutical fentanyl, 
with at least 123 fentanyl-associated 
deaths reported between 2000 and 
201215. Death cases resulting from 
self-administration of multiple fen-
tanyl patches were also reported in 
Algeria16 and Morocco17.
In recent years, several emerging 
synthetic opioids have been docu-
mented to cause serious adverse 
events and deaths18. In 2016, a record 
spike in drug overdoses in Midwest 
USA was attributed to carfentanil, 
and at least two carfentanil fatali-
ties in Canada were reported by the 
press. 
Markets for specific  
products
Products sold on the illicit synthetic 
opioid market are highly diversified, 
and often region-specific. Injecting 
15 NCIS. Deaths related to fentanyl misuse - An 
update: Fact Sheet. Retrieved 10 November 
2016. 
16 Salmi A. Fentanyl Patch... The Bad Use. 
Journal of Clinical Toxicology. 2015 Nov 
9;2015.
17 Serghini I. Fentanyl intoxication: case report. 
Reactions. 2015 Feb;1539:148-21.
18 UNODC EWA. Deaths associated with 
use of emerging synthetic opioids. [news 
announcement]. 2016 Nov. https://
www.unodc.org/LSS/Announcement/
Details/466aa396-492d-4129-a1bc-
f519ecb5d443#_ftn10
for the current overdose epidemic 
in the region. In the USA, fentanyl 
and its analogues have contributed 
to more than 5000 overdose deaths 
since fall 201311. In Canada, fentanyl 
was determined to be the cause, or 
a contributing factor, in at least 655 
death cases that occurred between 
2009 and 201412. In the European 
Union, death cases involving sub-
stances from the fentanyl group 
were first documented in the 1990s 
in Italy and Sweden, resurged in 
the early 2000s in Estonia (where 
most recorded overdose deaths are 
related to fentanyl and 3-methyl-
fentanyl use13), and have also been 
reported more recently in several 
other EU Member States, includ-
ing Finland, Germany, Greece, and 
the United Kingdom14. Australia 
has been experiencing a growing 
11 Green TC1, Gilbert M2. Counterfeit Medi-
cations and Fentanyl. JAMA Intern Med. 
2016 Oct 1;176(10):1555-1557.
12 Canadian Centre on Substance Abuse. 
Deaths involving fentanyl in Canada, 2009–
2014. CCENDU Bulletin, Ottawa, ON 
(2015)
13 Uusküla A, Raag M, Vorobjov S, Rüütel K, 
Lyubimova A, Levina OS, Heimer R. Non-
fatal overdoses and related risk factors among 
people who inject drugs in St. Petersburg, 
Russia and Kohtla-Järve, Estonia. BMC 
Public Health. 2015 Dec 18;15:1255.
14 Mounteney J, Giraudon I, Denissov G, Grif-
fiths P. Fentanyls: Are we missing the signs? 
Highly potent and on the rise in Europe. Int 
J Drug Policy. 2015 Jul;26(7):626-31.
Risk of exposure to  
fentanyl and its analogues
Overdose may also result from 
handling strong synthetic opioids 
without the precautions that pre-
vent the substance from being 
inhaled or absorbed through the 
skin or mucous membranes. Con-
tact with fentanyl or its analogues 
is so hazardous that both Canada 
and the USA recorded incidents of 
hospitalization of law enforcement 
officers that carried out seizures 
of such chemicals. The USA Drug 
Enforcement Administration (DEA) 
has recently released safety alerts 
on fentanyl and carfentanil, advis-
ing on steps to follow in situations 
where such drugs might be present, 
including immediate application of 
naloxone in case of exposure 9,10.
Overdose deaths
The nonmedical use of fentanyl and 
its analogues has resulted in thou-
sands of fatalities worldwide. In 
North America, illicitly manufactured 
fentanyl or fentanyl analogues have 
caused several epidemics of over-
dose deaths since the 1970s, and 
are to a large extent responsible 
9 https://ndews.umd.edu/sites/ndews.umd.edu/
files/DEA%20Fentanyl.pdf
10 https://www.dea.gov/divisions/hq/2016/
hq092216.shtml
Figure 3: Variable dose of active substance in clandestinely manufactured pills
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7furanylfentanyl, can be synthesized 
from NPP or ANPP via the Siegfried 
route. However, the majority of fen-
tanyl analogues that were put under 
international control between the 
sixties and the nineties and which do 
not appear to be linked to the cur-
rent opioid crisis in the USA, cannot 
readily be produced from NPP or 
ANPP.
Data reported to the UNODC on 
dismantled laboratories manufactur-
ing fentanyl include: three cases in 
Canada (one kitchen laboratory and 
one industrial-scale facility in 2011, 
and one medium- to large-scale facil-
ity in 2012), one kitchen laboratory 
in Slovakia (2011), three kitchen 
laboratories in the USA (one in 2013 
and two in 2015), one kitchen labo-
ratory in Germany (2015), and one 
case of manufacturing 3-methylfen-
tanyl in Russia (2014).29
Due to their extreme potencies, 
fentanyl and its analogues are often 
present in trace amounts in the 
products available, be it has phar-
maceuticals, illicitly-manufactured 
material or in admixture with for 
example, heroin. This makes detec-
tion of these substances extremely 
challenging in the forensic laboratory 
and could lead to under-reporting 
of the extent to which these prod-
ucts appear on the illicitly-used drug 
market. 
 
29 UNODC Annual Reports Questionnaires, 
2011-2015.
as hydrocodone/acetaminophen, 
the content of fentanyl in analysed 
pills varied between 600-6,900 μg/
pill24. New types of counterfeit pre-
scription pills containing synthetic 
opioids continue to appear25. Cases 
of fentanyl and analogues sold under 
the guise of heroin have also been 
observed in Europe. For example, 
ocfentanil has been sold on the 
hidden web as heroin, as revealed 
by analysis of samples collected in 
Spain and France26.
Manufacturing and  
trafficking
According to the DEA27, the current 
fentanyl crisis in the USA is largely 
fuelled by illicitly manufactured 
fentanyl and its analogues, which 
are either illegally imported as 
such or synthesized from imported 
precursors. The materials and appa-
ratus used in fentanyl synthesis and 
tableting are inexpensive and easy 
to obtain from online vendors, 
and the synthesis does not require 
sophisticated laboratory skills. This 
facilitates the entry into small-scale 
manufacturing for minor drug-traf-
ficking organizations. Most fentanyl 
recently seized in the USA was of 
non-pharmaceutical origin and syn-
thesized via the so-called Siegfried 
method, which was first described 
in the 1980s, and is relatively easy 
to perform.28 Precursor chemicals 
used in this route are N-phenethyl-
4-piperidone (NPP) or its derivative, 
4-anilino-N-phenethylpiperidine 
(ANPP). The majority of fentanyl 
analogues reported to the UNODC 
EWA in recent years, including 
acetylfentanyl, butyrfentanyl and 
24 Sutter ME, Gerona RR, Davis MT, Roche 
BM, Colby DK, Chenoweth JA, Adams AJ, 
Owen KP, Ford JB, Black HB, Albertson 
TE. Fatal Fentanyl: One Pill Can Kill. Acad 
Emerg Med. 2016 Jun 20.
25 Canadian Centre on Substance Abuse. Novel 
Synthetic Opioids in Counterfeit Pharma-
ceuticals and Other Illicit Street Drugs. 
CCENDU Bulletin, Ottawa, ON, June 2016
26 Quintana P, Ventura M, Grifell M, Palma 
A, Galindo L, Fornís I, Gil C, Carbón X, 
Caudevilla F, Farré M, Torrens M. The 
hidden web and the fentanyl problem: Detec-
tion of ocfentanil as an adulterant in heroin. 
International Journal of Drug Policy. 2016 
Nov 23.
27 DEA. Counterfeit prescription pills contain-
ing fentanyls: A global threat. DEA Intel-
ligence Brief. 2016 DEA-DCT-DIB-021-16.
28 DEA. Counterfeit prescription pills contain-
ing fentanyls: A global threat. DEA Intel-
ligence Brief. 2016 DEA-DCT-DIB-021-16.
fentanyl, diverted from pharma-
ceutical products (mostly extracted 
from transdermal patches), seems 
to be the major form of nonmedical 
fentanyl use in Australia19 and Ger-
many20, and was also reported in 
New Zealand21. Clandestinely man-
ufactured fentanyl or its analogues 
may be sold in solid or liquid form 
as the consumer’s drug of choice, 
such as is the case in Estonia, where 
fentanyl and 3-methylfentanyl are 
the most widely used opioids, and 
the primary injected drugs22.
In North America, heroin containing, 
or substituted with, drugs from the 
fentanyl group appeared already in 
the 1970s on the illicit drug market 
under names like “China White”, 
“Tango and Cash” or “Synthetic 
Heroin”. This trend is now making a 
comeback. Illicitly manufactured fen-
tanyl is most commonly mixed with 
or sold as white powder heroin, but 
also as cocaine products23 or black 
tar heroin. The most recent develop-
ment is the emergence of counterfeit 
pharmaceutical preparations 
containing illicitly manufactured 
fentanyl and its analogues. The sale 
of counterfeit products to unwitting 
customers increases the danger of 
overdose, as they do not know which 
substance they are consuming, and 
cannot determine the safe amount. 
Importantly, clandestine manufac-
turers often lack the ability to ensure 
uniform distribution of such highly 
potent substances in marketed prep-
arations, such as pills or powders. As 
a result, some pills or powders may 
contain a lethal dose. In a Californian 
study on an outbreak of poisonings 
caused by fentanyl-adulterated 
tablets purchased on the street 
19 Roxburgh A, Burns L, Drummer OH, Pil-
grim J, Farrell M, Degenhardt L. Trends in 
fentanyl prescriptions and fentanyl-related 
mortality in Australia. Drug Alcohol Rev. 
2013 May;32(3):269-75.
20 Erbas B, Arnold M. [Death from fentanyl: 
Causative and preventive approaches in 
Bavaria]. German. MMW Fortschr Med. 
2016 Feb 18;158(3):54-6.
21 Schauer CK, Shand JA, Reynolds TM. The 
Fentanyl Patch Boil-Up - A Novel Method of 
Opioid Abuse. Basic Clin Pharmacol Toxicol. 
2015 Nov;117(5):358-9.
22 Abel-Ollo K, Salekešin M, Vorobjov S, Vals 
K, Rüütel K. 2014 national report (2013 
data) to the EMCDDA by the Reitox 
National Focal Point.
23 Lucyk SN, Nelson LS. Novel Synthetic Opi-
oids: An Opioid Epidemic Within an Opioid 
Epidemic. Annals of emergency medicine. 
2017 Jan 1;69(1):91-3.
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Finland: International cooperation 
disrupts acetylfentanyl trafficking
HELSINKI, Finland – June 2015. After being notified 
by Belgium Customs, 2.36 grams of acetylfentanyl 
that had been sourced in China were seized in Fin-
land. The substance was in powder form and had 
been declared as acrylic paint phenolic resin for an 
individual in Finland. Previously, in 2014, Finland also 
reported three acetylfentanyl seizures in small quan-
tities that had been discovered in the post and had 
originated from China and Belgium.
European Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA); Europol. Acetylfentanyl. Luxembourg: Publications 
Office of the European Union, 2016.
OH3C
N
N
Source: UNODC
Japan: “Bath salt” containing acetylfen-
tanyl and 4-methoxy PV8 linked to a case 
of acute poisoning 
TOKYO, Japan – August 2016. In Japan, a forensic 
autopsy report on a man in his 30s has attributed 
this case of acute poisoning to a “bath salt” prod-
uct containing acetylfentanyl and 4-methoxy PV8 
(4-methoxy PHPP). It is suspected that the substances 
had been self-administered by an intravenous injec-
tion. The deceased had been a habitual user of “bath 
salts” and, for many years, had a history of metham-
phetamine use. A small plastic bag containing a pale 
brown white powder and a filled syringe were also 
found at the scene. 
Yonemitsu, K. et al. (2016) “A fatal poisoning case by intravenous 
injection of “bath salts” containing acetylfentanyl and 4-methoxy 
PV8.” Forensic Science International 267: e6–e9.
China: Six fentanyl analogues are placed 
under national control
BEIJING, China – September 2015. On 29 Septem-
ber, 2015 the Chinese Drug and Food Administration 
announced “Administrative Measures on Narcotics 
and Psychotropic Substances without Medical Use” 
by which 116 psychoactive substances, including 
six fentanyl analogues, were placed under national 
control. This decision came into effect on 1st Octo-
ber, 2015. The six fentanyl analogues that have been 
placed under national control are acetylfentanyl, 
butyrfentanyl, β-hydroxythiofentanyl, 4-fluorobu-
tyrfentanyl, isobutyrfentanyl and ocfentanil. Various 
other NPS, have also been included to the list of con-
trolled substances. 
UNODC Early Warning Advisory on New Psychoactive Sub-
stances. “Drug Laws/Individual Listing for CHINA.”
Source: UNODC
China: Chinese Customs seizes fentanyl 
and acetylfentanyl destined for Mexico
BEIJING, China – May 2015. In May 2015, Chinese 
Customs officials seized 46 kg of fentanyl and 26 kg 
of acetylfentanyl that had been concealed in a cargo 
container destined for Mexico. The substances had 
been transferred via five freight forwarders before 
arriving at customs where six customs officials 
became ill and one fell into a coma as a result of 
handling the drugs. Later, in March 2016, the Drug 
Enforcement Administration (DEA) and Homeland 
Security Investigations offices in the south-eastern 
United States also reported to have seized multiple 
shipments that had come from China containing 
mislabeled pill presses, as well as fentanyl, acetylfen-
tanyl, and butyrfentanyl.
Drug Enforcement Administration (DEA). DEA Intelligence Brief: 
Counterfeit Prescription Pills Containing Fentanyls: A Global 
Threat. July 2016.
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UNODC: International control of 
acetylfentanyl and MT-45 enters into 
force
VIENNA, Austria – May 2016. On 17 May 2016, the 
decision adopted by the Commission on Narcotic 
Drugs (CND) during its 59th Session in March 2016 to 
add the synthetic opioids acetylfentanyl to Schedule I 
and IV and MT-45 to Schedule I of the Single Conven-
tion on Narcotic Drugs of 1961 entered into force.
UNODC Early Warning Advisory on New Psychoactive Sub-
stances. “June 2016 – UNODC: Commission on Narcotic Drugs 
decision on international control of acetylfentanyl and MT-45 
enters into force.” June 2016. Available at: https://www.unodc.
org/LSS/Announcement/Details/3ec66e50-249f-438e-8a79-
470d5e269b8d
Source: UNODC
Sweden: Fentanyl analogues linked to 
several deaths and intoxications
STOCKHOLM, Sweden – August 2016. According to 
the National Board of Forensic Medicine, acrylfen-
tanyl has been linked to 20 deaths that occurred in 
Sweden between April and August 2016. Results from 
the Swedish early warning system called the STRIDA 
project also showed that among patients with sus-
pected NPS exposure at emergency departments in 
Sweden between April and November 2015, nine 
had analytically confirmed intoxications involving 
acetylfentanyl, three involving 4-methoxybutyrfen-
tanyl, one involving furanylfentanyl, and another 
involving a combination of 4-methoxybutyrfentanyl 
and furanylfentanyl. All of these patients were aged 
20-40 and mostly male. In 12 of the cases, patients 
were admitted to intensive care, where two required 
intubation and mechanical ventilation.
Helander A., Bäckberg M., and Beck O. (February 2016) 
“Intoxications involving the fentanyl analogs acetylfentanyl, 
4-methoxybutyrfentanyl and furanylfentanyl: results from the 
Swedish STRIDA project.” Clinical Toxicology 54 (4): 324-332.
Estonia: Furanylfentanyl is placed  
under national control
TALLINN, Estonia – July 2016. In July 2016, fura-
nylfentanyl was added to Schedule I of the narcotic 
and psychotropic substances regulation. According 
to the Chemical Department of the Estonian Forensic 
Science Institute, furanylfentanyl had been submit-
ted for analysis five times by June 2016 totaling a 
quantity of 14.185 grams. Although it has not yet 
been officially confirmed, the Estonian Forensic Sci-
ence Institute also suspects that the deaths of three 
people in Estonia might have been linked to the use 
of furanylfentanyl.
Europäische Kommission. “Notifizierungsangaben: Entwurf zur 
Änderung der Verordnung Nr. 73 des Sozialministers.” Available 
at: http://ec.europa.eu/growth/tools-databases/tris/de/index.
cfm/search/?trisaction=search.detail&year=2016&num=33
1&mLang=EN
O
O
N
N
Source: UNODC
UNODC: Increasing number of non- 
controlled fentanyl analogues reported 
to the Early Warning Advisory
VIENNA, Austria – November 2016. Of the 13 
non-controlled fentanyl analogues that have been 
reported by Member States to the UNODC Early 
Warning Advisory (EWA) by November 2016, eight 
have been reported within the last year. These 
substances include 4-methoxybutyrfentanyl, 
butyrfentanyl, despropionylfentanyl, despropionyl-
2-fluorofentanyl, furanylfentanyl, acrylfentanyl, 
para-fluoroisobutyrfentanyl, and valerylfentanyl. 
Additionally, (Iso)butyrfentanyl, (iso)butyr-F-fentanyl 
N-benzyl analogue, acetylfentanyl (controlled under 
Schedule I of the Single Convention on Narcotic Drugs 
of 1961), ocfentanil, and beta-hydroxy-thiofentanyl 
have also been reported to the EWA.
UNODC Early Warning Advisory on New Psychoactive Sub-
stances. “Search NPS Data” November 2016.
Source: UNODC
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Ireland: Authorities in Dublin and Cork 
investigate deaths involving fentanyl 
analogues
DUBLIN, Ireland – 2016. Between April and July 
2016, five deaths have been linked to the use of flu-
orofentanyl (isomer not specified) and ocfentanil in 
Dublin and Cork. As a result of these fentanyl-related 
deaths, the Health Service Executive (HSE) of Ireland 
issued an alert in July 2016 highlighting the dangers 
of fentanyl and its analogues. According to the HSE, 
fentanyl analogues might be sold to drug users as 
heroin in powder form possibly mixed with heroin 
or mixed with caffeine and paracetamol to mimic 
the effect of heroin.
Health Service Executive. “Fentanyl Implicated in Overdose 
Deaths.” 28 July, 2016. Available at: http://www.hse.ie/eng/
services/news/media/pressrel/Fentanlydeaths.html
Source: Ioulia Kondratovitch
World Health Organization: WHO Expert 
Committee on Drug Dependence reviews 
twelve psychoactive substances
GENEVA, Switzerland – November 2016. At the 
38th meeting of the WHO Expert Committee on Drug 
Dependence (ECDD) from 14 to 18 November 2016, 
twelve psychoactive substances have been consid-
ered for review, among them two synthetic opioids: 
U-47700 and butyrfentanyl. The other substances 
reviewed are: 4-MEC; 3-MMC; ethylone; pentedrone; 
ethylphenidate; methiopropamine; MDMB-CHMICA; 
5F-APINACA; JWH-073; and XLR-11. Recommenda-
tions from the WHO on whether or not to place 
specific substances under international control are 
addressed to the Secretary-General of the United 
Nations, and are subject to a vote by the United 
Nations Commission on Narcotic Drugs (CND).
UNODC Early Warning Advisory on New Psychoactive Substances. 
“August 2016 - World Health Organization: NPS to be reviewed 
for potential scheduling under the International Drug Control 
Conventions.” August 2016. 
Belgium: Belgian Customs Service  
reports seizures of acetylfentanyl en 
route to France and Germany
Brussels, Belgium – 2015. Since June 2015, the Bel-
gian Customs Service has reported of three seizure 
cases of acetylfentanyl that were perceived to have 
been sourced in China. In the first case, 103.57 g of 
packaged acetylfentanyl that was seized in the post 
and intended for onward trafficking to an individual in 
France, while the second seizure case involved 11.30 
g of packaged acetylfentanyl that was also discovered 
in the post and intended for onward trafficking to 
an individual in Germany. In the third seizure case, 
three plastic sachets were discovered in the postal 
stream in a plastic package containing 2.42 grams 
of propylfentanyl, 2.41 grams of acetylfentanyl and 
2.40 grams of flubromazepam. According to the Bel-
gian Customs Service, the substances were sourced 
in China and intended for onward trafficking to an 
individual in Germany.
European Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA); Europol. Acetylfentanyl. Luxembourg: Publica-
tions Office of the European Union, 2016.
Brazil: Fentanyl and butylone implicated 
in acute poisonings
SÃO PAULO, Brazil – September 2016. In September 
2016, the Laboratory of the Toxicology Faculty of 
Medicine (FCM) of Unicamp reported that fentanyl 
and butylone were suspected to have been linked to 
six cases of acute poisoning in August 2016 in Campi-
nas, Sumaré, and Indaiatuba, in Brazil. According to 
toxicologists at the Center of Intoxication of Unicamp 
(JRC), drug users might not have been aware that 
they were using fentanyl and butylone because of 
the similarities in appearance to LSD and other drugs. 
The JRC has issued alerts to all emergency rooms in 
São Paulo to notify them of the symptoms and effects 
that these substances can have on drug users.
ProMED-mail International Society for Infectious Diseases. “Fen-
tanil e butilona - Brasil (SP), uso recreacional, intoxicação, alerta.” 
10 September, 2016. Available at: http://www.promedmail.
org/direct.php?id=20160910.4479040
Source: UNODC
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Canada: Promoting safe handling of  
fentanyl by first responders
BRITISH COLUMBIA, Canada – June 2016. Spon-
sored by the Justice Institute of British Columbia and 
the British Columbia Association of Chiefs of Police, 
the Royal Canadian Mounted Police (RCMP) has 
provided two-day workshops to train police, para-
medics, firefighters, correctional officers, Canada 
Border Services agents and Transport Canada staff 
in safe handling of fentanyl in British Columbia. The 
RCMP also raised awareness of the dangers of fen-
tanyl to first responders and the general public by 
releasing a video in September 2016 that featured 
two British Columbia RCMP officers who became sick 
immediately after inhaling or touching fentanyl that 
belonged to people they had come across during a 
car inspection.
British Columbia Government News. “Workshops safeguard first 
responders from deadly fentanyl.” 14 June 2016. Available at: 
https://news.gov.bc.ca/releases/2016PSSG0118-001025
Royal Canadian Mounted Police (RCMP). “Video on the dangers 
of fentanyl.” Available at: http://www.rcmp.gc.ca/en/fentanyl-
video?nr
Source: RCMP
Canada: Health Canada proposes  
national control of fentanyl precursor 
chemicals
OTTAWA, Canada – September 2016. On 3 Septem-
ber 2016, Health Canada issued a notice proposing to 
add six precursor chemicals used in the production 
of fentanyl to Part 1 of Schedule VI of the Controlled 
Drugs and Substances Act and to the schedule of the 
Precursor Control Regulations as Class A precursor 
chemicals: propionyl chloride; 1-phenethyl-4-piper-
idone (NPP) and its salts; 4-piperidone and its salts; 
norfentanyl (N-phenyl-N-piperidin-4-ylpropanamide) 
and its salts; 1-phenethylpiperidin-4-ylidenephenyl-
amine and its salts; and N-phenyl-4-piperidinamine 
and its salts. These regulatory amendments came 
into force on 30 November 2016.
Government of Canada. “Canada Gazette.” Vol. 150, No. 36, Sep-
tember 3, 2016. Available at: http://www.gazette.gc.ca/rp-pr/
p1/2016/2016-09-03/html/notice-avis-eng.php
United States: Counterfeit oxycodone 
and Xanax tablets contain fentanyl and 
analogues
LOS ANGELES, California – March 2016. In Los 
Angeles, the Drug Enforcement Administration (DEA) 
seized a counterfeit prescription pill manufactur-
ing site in March 2016 that had employed the use 
of fentanyl and other synthetic opiates. Previously, 
in January 2016, the DEA of New Jersey arrested 
a counterfeit prescription pill producer who had 
manufactured tablets in New York to look like 30 
milligram oxycodone tablets, but in fact contained 
either fentanyl citrate or acetylfentanyl. According to 
the DEA, nine people died of the use of counterfeit 
Xanax® tablets containing fentanyl in Pinellas County, 
in Florida between January and March 2016. In March 
and April 2016, another 52 overdoses and 10 deaths 
occurred in Sacramento, California, through the use 
of counterfeit Norco® pills containing fentanyl.
Drug Enforcement Administration (DEA). DEA Intelligence Brief: 
Counterfeit Prescription Pills Containing Fentanyls: A Global 
Threat. July 2016.
Source: DEA
United States: Fentanyl analogues are 
placed under national control
WASHINGTON D.C., United States – 2016. Based 
on the recent surge of fentanyl-related deaths, 
the DEA issued a nationwide alert on fentanyl and 
its analogues in March 2015. Since 17 July 2015, 
acetylfentanyl is a controlled substance in the United 
States under Schedule I of the Controlled Substances 
Act. In September 2016, the DEA issued a notice of 
intent to temporarily schedule the synthetic opioid 
furanylfentanyl.
UNODC Early Warning Advisory on New Psychoactive Substances. 
“July 2015 – United States of America: Acetylfentanyl placed under 
temporary control.” July 2015. Available at: https://www.unodc.
org/LSS/Announcement/Details/a9a23075-6d57-4cc2-9a49-
0bcce189e776
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